Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6490
    +0.0001 (+0.01%)
     
  • OIL

    82.66
    -0.70 (-0.84%)
     
  • GOLD

    2,336.20
    -5.90 (-0.25%)
     
  • Bitcoin AUD

    99,660.32
    -3,112.25 (-3.03%)
     
  • CMC Crypto 200

    1,392.98
    -31.12 (-2.18%)
     
  • AUD/EUR

    0.6070
    +0.0013 (+0.22%)
     
  • AUD/NZD

    1.0949
    +0.0019 (+0.17%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,441.74
    -29.73 (-0.17%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,329.53
    -174.16 (-0.45%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market

1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market

Analysts are bullish on Biogen's Alzheimer's drug, Leqembi, projecting it may generate over $10 billion in sales at its peak.